Back
Preformed Line Products Vs. Monopar Therapeutics Industry Stock Comparison
Sell
44
PLPC
Preformed Line Products
Last Price:
$137.88
Seasonality Move:
5.47%
Buy
51
MNPR
Monopar Therapeutics
Last Price:
$38.89
Seasonality Move:
-7.08%
Sell
44
Preformed Line Products (PLPC)
is a Sell
Is Preformed Line Products a Buy, Sell or Hold?
-
The current Preformed Line Products [PLPC] share price is $136.91. The Score for PLPC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
PLPC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $39.59. The Score for MNPR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLPC Stock Price Chart
What is Preformed Line Products's stock price today?
-
The Preformed Line Products share price today is $136.91The current trend is moderately bearish and PLPC is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $39.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
PLPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.09 | Sell |
| Chaikin Money Flow: | -19350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (136.38 - 147.72) | Sell |
| Bollinger Bands (100): | (127.43 - 143.57) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 57.1 | Buy |
| Chaikin Money Flow: | 2638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.98 - 40.08) | Buy |
| Bollinger Bands (100): | (23.95 - 40.87) | Buy |
PLPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.28 | Sell |
| 20-day SMA: | 140.16 | Sell |
| 50-day SMA: | 138.21 | Sell |
| 200-day SMA: | 129.5 | Buy |
| 8-day EMA: | 138.5 | Sell |
| 20-day EMA: | 138.8 | Sell |
| 50-day EMA: | 137.73 | Sell |
| 200-day EMA: | 132.69 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Buy |
| 20-day SMA: | 35.93 | Buy |
| 50-day SMA: | 36.84 | Buy |
| 200-day SMA: | 19.47 | Buy |
| 8-day EMA: | 36.55 | Buy |
| 20-day EMA: | 35.63 | Buy |
| 50-day EMA: | 34.92 | Buy |
| 200-day EMA: | 23.59 | Buy |
Preformed Line Products Earnings Growth & PLPC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
Preformed Line Products Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||